On the basis of limited experimental data from animal studies and from extensive clinical data the authors tentatively suggest that estrogens at low dosage levels are not carcinogenic and thus not subject to the Delaney clause. Procedures for determining the safety of estrogenic hormone residues in animal products are outlined.
No takes yet. Share an insight, caveat, or question.
Cole et al. (1975) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: